Q1 2025 Bruker Corp Earnings Call Transcript
Key Points
- Bruker Corp (BRKR) reported double-digit revenue growth in the first quarter of 2025, with an 11% increase year-over-year to $801.4 million.
- The company achieved 5.1% organic revenue growth in its Bruker Scientific Instruments segment, exceeding expectations.
- Bruker Corp (BRKR) launched several innovative products in spatial biology, cellular analysis, NMR, microbiology, and molecular diagnostics, enhancing its high-value offerings.
- The biopharma end markets showed mid-single-digit growth, indicating strengthening demand.
- Bruker Corp (BRKR) is implementing mitigation actions, including pricing strategies and supply chain reengineering, to offset more than half of the operating profit headwinds in 2025, with full offset expected by 2026.
- Bruker Corp (BRKR) faces approximately $100 million in revenue headwinds for fiscal year 2025 due to US policy changes, slower China stimulus funding, and new tariffs.
- The company's non-GAAP operating margin decreased to 12.7% in Q1 2025, down from the previous year, due to M&A dilution and FX currency headwinds.
- US academic and government (ACA/GOV) revenue is expected to decline by 20% to 25% in 2025, impacting overall performance.
- China's ACA/GOV revenue is affected by slow stimulus funding release, contributing to uncertainties in the market.
- Bruker Corp (BRKR) anticipates a $90 million gross headwind to operating profit in 2025 due to US ACA/GOV disruption and new tariffs, before mitigation actions.
Good day, and welcome to the Bruker Corporation first quarter 2025 earnings conference call. (Operator Instructions)
Please note this event is being recorded. I would like to turn the conference over to Joe Kostka, Director of Investor Relations. Please go ahead.
Good morning. I would like to welcome everyone to Bruker Corporation's first quarter 2025 earnings conference call. My name is Joe Kostka, and I am the Director of Bruker Investor Relations. Joining me on today's call are Frank Laukien, our President and CEO; and Gerald Herman, our EVP and CFO.
In addition to the earnings release we issued earlier today, during today's conference call, we will be referencing a slide presentation that can be downloaded from the Events and Presentations section of Bruker's Investor Relations website. During today's call, we will be highlighting non-GAAP financial information.
Reconciliations of our non-GAAP to GAAP finical measures are included in our earnings release and are posted on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
